[{"NetIncomeLoss_1_Q3_USD":-9545000.0,"OperatingLeaseExpense_1_Q3_USD":600000.0,"OperatingLeaseExpense_3_Q3_USD":1600000.0,"AssetsCurrent_0_Q3_USD":223593000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2046000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":117065000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":117065000.0,"MarketableSecuritiesRealizedGainLoss_3_Q3_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-2003000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.0166,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":37000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q3_pure":0.6815,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.6818,"AccruedLiabilitiesCurrent_0_Q3_USD":343000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q3_pure":0.0039,"OtherNoncashIncomeExpense_3_Q3_USD":-63000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":80104000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":22772000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":117500000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OperatingLeaseRightOfUseAsset_0_Q3_USD":10632000.0,"ShareBasedCompensation_3_Q3_USD":4761000.0,"Assets_0_Q3_USD":248812000.0,"CommonStockSharesIssued_0_Q3_shares":38790189.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":80510000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2194000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1276000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":2289000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":6079490.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6079490.0,"ContractWithCustomerLiability_0_Q3_USD":20600000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":7793000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":35460092.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":5.4,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":32845583.0,"ProvisionForDoubtfulAccounts_1_Q3_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":120327000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":1500000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":4279000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q3_USD":0.0,"NumberOfReportableSegments_3_Q3_Segment":1.0,"IncomeTaxExpenseBenefit_1_Q3_USD":5000.0,"CostsAndExpenses_3_Q3_USD":87248000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":39000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-4000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":5000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":15976000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":7193000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":20048000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":505000.0,"AccountsReceivableNetCurrent_0_Q3_USD":5903000.0,"CostsAndExpenses_1_Q3_USD":29469000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":93000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-27939000.0,"OtherDeferredCostsNet_0_Q3_USD":3633000.0,"OperatingLeaseLiability_0_Q3_USD":11199000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-75000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":45000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q3_shares":0.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":471000.0,"Liabilities_0_Q3_USD":45272000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":372027000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":8897000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":133245000.0,"OtherAssetsNoncurrent_0_Q3_USD":1852000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1628000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-9614000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-27896000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-9545000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_3_Q3_pure":0.25,"ShortTermInvestments_0_Q3_USD":72818000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":11.71,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2065000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2558000.0,"CostOfRevenue_1_Q3_USD":14483000.0,"CostOfRevenue_3_Q3_USD":44428000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":35460092.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":32845583.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":2635000.0,"LiabilitiesCurrent_0_Q3_USD":35904000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-40121000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-2000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1690000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":4761000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-9540000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-27900000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":13100000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":6000.0,"AccountsPayableCurrent_0_Q3_USD":6514000.0,"InterestExpense_3_Q3_USD":2000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5359000.0,"NetIncomeLoss_3_Q3_USD":-27939000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":12735000.0,"DividendsCommonStock_3_Q3_USD":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"OperatingLeasePayments_3_Q3_USD":1200000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":631000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q3_pure":0.0037,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.0036,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":133245000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.107,"AccruedIncomeTaxesCurrent_0_Q3_USD":46000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2920000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":-4000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q3_pure":0.6778,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.6174,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":10600000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":2113000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":31700000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":2603000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":20593000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"InvestmentIncomeInterest_1_Q3_USD":117000.0,"InvestmentIncomeInterest_3_Q3_USD":873000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":100000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":248812000.0,"OperatingIncomeLoss_1_Q3_USD":-9653000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q3_shares":0.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_3_Q3_shares":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":19816000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":58472000.0,"CommonStockValueOutstanding_0_Q3_USD":4000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"OperatingIncomeLoss_3_Q3_USD":-28776000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":5432000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4761000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":78199000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-168528000.0,"DebtLongtermAndShorttermCombinedAmount_0_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2409000.0,"StockholdersEquity_0_Q3_USD":203540000.0,"OtherLiabilitiesCurrent_0_Q3_USD":674000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":471000.0,"ProfitLoss_3_Q3_USD":-27939000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.27,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.85,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":9800000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":1174000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2302000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":11400000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1690000.0,"CommonStockSharesOutstanding_0_Q3_shares":38790189.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-15383000.0,"Ticker":"PSNL","CIK":"1527753","name":"PERSONALIS, INC.","OfficialName":"Personalis Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"307257592.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]